JNJ vs TSLA
AI-powered side-by-side analysis. Updated every 2 hours.
Divergence: JNJ is bullish while TSLA is bearish. Diverging directions between related stocks can signal sector rotation or company-specific catalysts.
Johnson & Johnson Eyes Double-Digit Revenue Growth
- • JNJ stock up 18.74% in Q1 2026
- • FDA approved ICOTYDE, potentially $5B-$10B sales
- • Insiders sold $127M shares recently
Tesla faces cash strain amid delivery miss
- • Tesla stock down 23% in 2026 year-to-date
- • Q1 2026 deliveries at 358,023 vehicles, 6% YoY increase but below consensus
- • Tesla plans $20B+ capex in 2026 with potential $3B negative free cash flow for Terafab
How This Works
The Read analyzes 50+ financial sources every 2 hours and maintains AI-scored positions on 40+ stocks. Each entity is independently evaluated based on insider activity, analyst ratings, earnings data, SEC filings, and news signals. See our track record.
This comparison updates automatically whenever either stock's analysis changes. Every prediction is timestamped and scored against real prices.
More Comparisons
Explore more